Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,975JPY
4 Aug 2015
Change (% chg)

¥54 (+2.78%)
Prev Close
¥1,922
Open
¥1,932
Day's High
¥1,978
Day's Low
¥1,917
Volume
8,022,600
Avg. Vol
7,513,810
52-wk High
¥2,047
52-wk Low
¥1,390

4503.T

Chart for 4503.T

About

Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea and Taiwan, through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive... (more)

Overall

Beta: 0.55
Market Cap(Mil.): ¥4,269,233.00
Shares Outstanding(Mil.): 2,221.82
Dividend: 16.00
Yield (%): 1.56

Financials

  4503.T Industry Sector
P/E (TTM): 29.29 36.80 40.04
EPS (TTM): 65.60 -- --
ROI: 10.86 16.38 15.66
ROE: 11.28 17.14 16.66
Search Stocks

US FDA approves Astellas drug for invasive fungal infections

- U.S. health regulators on Friday approved Japanese drugmaker Astellas Pharma Inc's drug for the treatment of two rare, often fatal invasive fungal infections that target patients with blood cancers.

06 Mar 2015

UPDATE 1-US FDA approves Astellas drug for invasive fungal infections

March 6 - U.S. health regulators on Friday approved Japanese drugmaker Astellas Pharma Inc's drug for the treatment of two rare, often fatal invasive fungal infections that target patients with blood cancers.

06 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
£10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks